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ABSTRACT This study makes use of whole 
embryo culture to investigate the potential em- 
bryotoxicity of benzyloxycarbonyl-phenylalanine- discussed. G 1994 Wiiey-tiss, Inc. 
a I a nine- d i a zo m et h a ne and 
tionships between interruption of VYS-mediated 
nutritional processes and embryonic cell death are 
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benzyloxycarbonyl- phenylolanine- phenylalanine- 
diazomethane (Z-Phe-Phe-CHN,), two low molec- 
ular weight, active site-directed and irreversible in- 
hibitors of the lysosomal cysteine proteinases. Pep- 
tidy1 diazomethanes are the most specific inhibitors 
available for lysosomal cysteine proteinases and 
car, be hypothesized TO interrJpt visceral yolk soc 
(VYS)-mediated nutrition during early organogen- 
esis. When added directly to the culture medium of 
gestational day 10-1 1 rat conceptuses, both com- 
pounds inhibited lysosomal cysteine proteinase 
activity in the VYS in a concentration-dependent 
fashion that correlated with the degree of embryo- 
toxicity observed. Z-Phe-Ala-CHN2 and Z-Phe- 
Phe-CHN, were also found to increase the protein 
content of the VYS, even though all other conceptal 
growth parameters decreased. This effect was de- 
pendent on the serum content of the culture me- 
dium and the exposure time. Histological examina- 
tion of Z-Phe-Ala-CHN2-treated conceptuses 
revealed a dramatic increase in the size and num- 
ber of vacuoles in the VYS endoderm epithelium, 
suggestive of inhibition of VYS protealysis. At the 
same time, excessive cell death was observed 
throughout the neuroepithelium and in specific re- 
gions of the mesenchyme of the corresponding 
embryos. This cell death manifested morphological 
characteristics of apoptosis and could be detected 
by supravital staininq with Nile Blue Sulphate. 
In vitro studies performed by Freeman and col- 
leagues ('81; Freeman and Lloyd, '83a) have shown 
that during early organogenesis and prior to the estab- 
lishment of the functional placenta, the rat  visceral 
yolk sac (VYS) supplies the rapidly developing concep- 
tus with amino acids used for de novo protein synthe- 
sis. This process, known as histiotrophic nutrition, in- 
volves the endocytosis and degradation of exogenous 
proteins by the VYS endoderm epithelium. More recent 
experiments have demonstrated the quantitative sig- 
nificance of this pathway: it has been estimated that 
86% of the serine (Rowe and Kalaizis, '85) and 99% of 
the leucine (Beckman et al., '90, '91) incorporated into 
new conceptal proteins is derived from VYS proteoly- 
sis. The importance of histiotrophic nutrition for nor- 
mal embryonic development in vivo has been suggested 
by the teratogenicity of several agents known to dis- 
rupt this process (Freeman and Lloyd, '83b, '86; Brent 
et al., '90). 
Notable among the group of embryotoxicants shown 
to interrupt histiotrophic nutrition is the protease in- 
hibitor leupeptin. Leupeptin has been used not only to 
demonstrate that inhibition of VYS proteolysis leads to 
embryotoxicity, but also to make inferences about the 
identity of the proteolytic enzymes involved. The po- 
tent inhibitory effect of leupeptin on VYS proteolysis 
has been taken as evidence that the lysosomal cysteine 
proteinases (cathepsins B, H, and L) are responsible for 
These' findings provhe additional evidence in 
support of the hypothesis that lysosomal cysteine 
proteinoses play a critical role in VYS-mediated 
histiotrophic nutrition arid suggest that peptidyl di- Received january 12, 1994; accepted jUly 5, 1994. 
may be useful in further character- 
ization of these enzymes. The possible direct effects 
of these inhibitors on embryonic cells and the rela- 
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VYS proteolysis (Knowles and Ballard, '81; Freeman 
and Lloyd, '83b; Freeman and Brown, '85). It is known, 
however, that in addition to the lysosomal cysteine pro- 
teinases, leupeptin can also inhibit a number of serine 
proteases such as plasmin, trypsin, and kallikrein 
(Ishii and Kasai, '81; Umezawa, '821, as well as the 
calcium-activated neutral proteases (calpains) (Parkes 
et al., '85; Rich, '86). This lack of specificity of leupeptin 
and related peptide aldehydes has led researchers to 
search for new inhibitors for the characterization of 
lysosomal cysteine proteinases. 
Several classes of cysteine proteinase inhibitors 
displaying greater specificity have subsequently been 
developed, including the peptide epoxides (Hanada et 
al., '78) and the peptidyl diazomethanes (Leary et al., 
'77). Unlike leupeptin, both the peptide epoxides and 
peptidyl diazomethanes can distinguish between cys- 
teine and serine proteinases. However, the peptide 
epoxides (of which E-64 is a member) have also been 
found to be potent inhibitors of calpains (Parkes et al., 
'85). The peptidyl diazomethanes are the most specific 
inhibitors of lysosomal cysteine proteinases currently 
available, being inactive against all other classes of 
proteinases including calpains (Green and Shaw, '81; 
Crawford et al., '88). The peptide portion of these 
inhibitors enables them to enter the active site of the 
enzyme where irreversible inactivation occurs via 
alkylation of the catalytic cysteine moiety (for reviews 
see Rich, '86; Shaw, '90). Mason et al. ('89) have shown 
that these inhibitors act as affinity labels for lyso- 
soma1 cysteine proteinases. After exposing cultured 
cells to a radiolabeled peptide diazornethane, they 
found only the active forms of cathepsins B and L were 
labeled in cell extracts. This illustrates the specificity 
of these reagents since even the precursor forms of the 
target enzymes (procathepsins) remained unlabeled 
until they were processed to an active form. Another 
advantage of the peptidyl diazomethanes is the ability 
to distinguish between the enzymes cathepsin B and 
cathepsin L through alterations in the peptide group, 
since these two enzymes are indistinguishable in 
terms of their sensitivity to leupeptin and the peptide 
epoxides (all three inhibitor classes are much less 
effective against cathepsin H). These unique proper- 
ties of the peptidyl diazomethanes make them useful 
tools for the investigation of proteolytic enzymes in the 
rat conceptus. 
If the lysosomal cysteine proteinases are indeed the 
target for embryotoxicants such as leupeptin, it could 
be hypothesized that the peptidyl diazomethanes would 
also cause embryotoxicity in the rat and manifest 
evidence of perturbed histiotrophic nutrition. In order 
to test this hypothesis, we exposed early organogene- 
sis-stage rat conceptuses growing in whole embryo 
culture to two peptidyl diazomethanes, 'benzyloxycar- 
bonyl-phenylalanine-alanine-diazomethane (Z-Phe- 
Ala-CHN,) and benzyloxycarbonyl-plienylalanine- 
phenylalanine-diazomethane (Z-Phe-Phe-CHN,), and 
evaluated their response biochemically and morpholog- 
ically. 
MATERIALS AND METHODS 
Chemicals 
Benzyloxycarbonyl-phenylalanine-arginine-7-amino- 
4-methyl coumarin (Z-Phe-Arg-7AMC) and Z-Phe-Phe- 
CHNz were from Bachem Biochemical (Cambridge, 
MA); Z-Phe-Ala-CHN, and 7-amino-4-methyl cou- 
marin (7AMC) were obtained from Bachem California 
(Torrance, CA). Nile Blue Sulphate (NBS) was from 
Sigma Chemical Co. (St. Louis, MO). All other reagents 
were of the highest purity available and were obtained 
from common sources. 
Embryo culture 
Time-mated primigravida Sprague-Dawley rats 
were obtained from the University of Michigan Repro- 
ductive Sciences Program Animal Core Facility on ges- 
tational days (GD) 6-9 (sperm positive vaginal smear 
= GD 0) and maintained on a 14 hour lightilo hour 
dark cycle with free access to food and water. Concep- 
tuses were explanted as previously described (Fantel et 
al., '79) between 8-11 A.M. on GD 10, and placed in 
culture bottles containing 33% rat serum in Hank's 
balanced salt solution (HBSS; pH = 7.4) supplemented 
with penicillin G (100 IU/ml) and streptomycin (50 IUi 
ml). Embryos had elevated head folds and 7-9 somites 
at  the beginning of the culture period. A maximum of 
1 conceptusiml was used in a total volume of 10-15 ml 
of medium. The medium had been warmed to 37°C and 
gassed with 20% 0,:5% co,:75% N, at  the start of the 
culture period. Stock Z-Phe-Ala-CHN, or Z-Phe-Phe- 
CHN, in dimethylsulfoxide (DMSO) was added directly 
to the culture medium just prior to adding the concep- 
tuses. Control cultures received an amount of DMSO 
equivalent to the highest concentration of inhibitor 
stock. This volume did not exceed 0.01% of the volume 
of culture medium. The culture bottles were sealed and 
placed in a roller incubator overnight and regassed 
with 95% 02:5% CO, on the following morning (GD 
11). Assessments took place at approximately 1 P.M. on 
GD 11. 
Morphology assessment 
Conceptuses were removed from culture, rinsed once 
with HBSS, and placed in warm HBSS for assessment 
of viability (heartbeat and yolk sac circulation) and 
malformations. Assessments were performed under a 
dissecting microscope and conducted blind in order to 
minimize bias. Yolk sac morphology was scored numer- 
ically according to the criteria of Seegmiller et al. ('911, 
with 0 being given to a healthy VYS and scores of 1-4 
to increasingly severe VYS abnormalities (diminished 
pigment, vasculature, and circulation). The yolk sac 
was removed by dissection and measurements were 
taken of embryonic crown-rump length and head size 
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with an ocular micrometer. The embryos were further 
evaluated for somite number, neural tube closure, ax- 
ial rotation, and morphologic abnormalities. The em- 
bryos and yolk sacs were individually placed in sodium 
phosphate buffer (50 mM containing 1 mM EDTA, pH 
= 6.0) on ice, sonically disrupted, and frozen at -70°C 
for subsequent determinations of protein content, DNA 
content, and cathepsin activity. 
Protein and DNA assays 
Protein content was determined by the method of 
Bradford ('76) and modified for 96-well microtiter 
plates as  described in Harris e t  al. ('88). Bovine gamma 
globulin was used as a standard. DNA content was 
determined fluorometrically by the method of Labarca 
and Paigen ('801, using bovine DNA as a standard. 
Lysosomal cysteine proteinase activity 
The combined hydrolytic activity of the lysosomal 
cysteine proteinases cathepsin B and L was determined 
using the fluorometric substrate Z-Phe-Arg-7AMC. A 
modification of the method of Barrett and Kirschke 
('81) for cathepsin L was employed. Briefly, aliquots of 
VYS homogenates were diluted in 0.1% Triton X-100, 
and then mixed with 8 mM dithiothreitol (DTT) in or- 
der to activate the enzyme. After a 1 minute activation 
period, the enzyme solution was combined with sub- 
strate and incubated for an  additional 10 minutes a t  
37°C. The final reaction mixture contained 5 mM 
Z-Phe-Arg-7AMC, 100 mM sodium acetate buffer, 1 
mM EDTA, and 2 mM DTT (pH = 5.5). The reaction 
was stopped by adding ice-cold 200 mM sodium mono- 
chloroacetate (pH = 4.31, and the fluorescence of the 
7AMC product determined a t  370 nm excitation and 
460 nm emission using a Perkin-Elmer Model LS-5 flu- 
orescence spectrophotometer (Perkin-Elmer, Oak 
Brook, IL). The instrument was standardized with au- 
thentic 7AMC. One milliunit (mu)  of activity is de- 
fined as  that which liberates 1 nmol of productimin. 
Histology 
Representative samples from control, 2.5 pM, 5.0 
pM, and 10 pM Z-Phe-Ala-CHN,-treated conceptuses 
from two separate experiments were processed and 
evaluated. At the end of the culture period (GD 11.51, 
conceptuses were rinsed in warm HBSS and placed in 
Karnovsky's fixative at room temperature. The VYSs 
were dissected free of the embryo and the amnion was 
ruptured to allow fixative to reach the embryos. After 
fixation, the embryos and VYSs were dehydrated and 
embedded in glycol methacrylate polymer, cut in 5 pm 
transverse sections, and stained with hematoxylin and 
eosin (H&E). A Leitz Aristoplan microscope with a 
Wild camera attachment was used for examination and 
photography of the sections. 
NBS staining 
At the end of the culture period, control and Z-Phe- 
Ala-CHN,-treated conceptuses were removed from the 
culture medium and rinsed in warm HBSS. The em- 
bryos were dissected free of their extraembryonic mem- 
branes and placed in 50 ml roller bottles containing a 
0.002% (w/v) solution of NBS in lactated Ringer's solu- 
tion. The bottles were roller incubated for 30 minutes 
at 37"C, after which the embryos were removed and 
rinsed well in HBSS. Examination and photography 
were performed on a Leitz M8 dissecting microscope 
with a Wild camera attachment. 
Statistical analysis 
One-way analysis of variance (ANOVA) was used to 
determine overall differences between treatment 
means. This was followed by Fisher's protected least 
significant differences test (PLSD) test for pairwise 
comparisons. The chi-square test was used for analysis 
of malformation incidence. P < 0.05 was considered 
significant. 
RESULTS 
The addition of Z-Phe-Ala-CHN, to culture medium 
containing whole conceptuses on GD 10 inhibited the 
overall growth of the VYS and the development of the 
vitelline vasculature by GD 11 (Fig. 1A). Embryos 
taken from these conceptuses likewise display concen- 
tration-related growth retardation and dysmorphogen- 
esis (Fig. 1B). Table 1 summarizes the effects of Z-Phe- 
Ala-CHN, on the development of organogenesis-stage 
rat conceptuses grown in vitro for 26 hours. Initial in- 
hibitor concentrations of 1-20 pM caused concentra- 
tion-related decreases in crown-rump length (to 62% of 
control at 20 pM, P < 0.001), head length (to 53% of 
control at 20 pM, P < 0.001), and somite number (to 
69% of control a t  20 pM, P < 0.001). The incidence of 
abnormal VYSs and dysmorphogenic embryos (100% at 
10 pM) increased in a concentration-related fashion, 
while viability (as assessed by heartbeat and VYS cir- 
culation) was not dramatically reduced (90% a t  20 pM). 
Similar results were obtained if Z-Phe-Phe-CHN, was 
used in the same experimental protocol (Table 2), al- 
though this inhibitor appeared slightly less potent 
than Z-Phe-Ala-CHN,. 
The type and incidence of dysmorphogenesis pro- 
duced by Z-Phe-Ala-CHN, exposure is shown in Table 
3. Abnormal morphology in the craniofacial region was 
the most prominent effect noted, with anophthalmia 
and lack of cranial neural tube expansion occurring in 
100% of the embryos exposed to 20 KM inhibitor. These 
changes, together with blisters and opaque necrotic ar- 
eas in the craniofacial region, increased in incidence 
and severity as  the concentration of Z-Phe-Ala-CHN, 
was increased. 2-Phe-Ala-CHN, treatment also pro- 
duced abnormal axial rotation and shortening of the 
trunk in a smaller percentage of treated embryos (22% 
and 33%, respectively, a t  20 pM), but these effects did 
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Fig. 1. Effect of Z-Phe-Ala-CHN, on VYS and embryo morphology. 
A Control and 10 pM Z-Phe-Ala-CHN,-treated whole conceptuses a t  
the end of the culture period (GD 11.5). Control is on the left. Note the 
decreased VYS vasculature (V) in the treated conceptus. ~ 1 4 .  
B: Examples of control, 2.5 pM, and 5.0 pM Z-Phe-Ala-CHN,-treated 
embryos at  the end of the culture period. The extraembryonic mem- 
branes have been removed for photography. x 13. 
not appear to follow a clear concentration-response re- 
lationship. The morphologic effects of 2-Phe-Ala-CHN, 
were closely paralleled by those observed for Z-Phe- 
Phe-CHN, (data not shown). 
Biochemical growth parameters are presented in 
Figure 2. Z-Phe-Ala-CHN, exposure decreased both 
DNA and protein content of embryos to 26% and 27% of 
control a t  20 pM, respectively, by the end of the culture 
period. In the VYS, however, changes in protein and 
DNA content did not parallel one another. Only DNA 
content decreased in a typical concentration-response 
pattern (to 61% of control at 20 pM, P < 0.001). 
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TABLE 1. Effects of Z-Phe-Ala-CHN, on rat embryonic development in vitro' 
Crown-rump Yolk sac 
Inhibitor length Head length Mean yolk diameter 
concentration % Viable' % Dvsmor~h ic~  (mm -t SD) (mm -t SD) Somites (fSD) sac score (mm ? SD) 
DMSO control 100 (31) 6 (2i31) 3.4 % 0.3 1.7 k 0.2 23 2 1 0 3.6 2 0.2 
1.0 pM 100 (5) 0 (015) 3.2 0.2 1.7 * 0.1 22 * 1 0 3.5 f 0.2 
2.5 pM 100 (21) 43 (9i21)* 3.0 ? 0.2** 1.5 * 0.2** 21 f I* 1 ND 
5.0 pM 96 (25) 96 (23/24)* 2.8 ? 0.2** 1.4 * 0.2** 20 -c 2" 1 3.4 k 0.2 
10.0 pM 93 (27) 100 (25125)" 2.4 f 0.2"" 1.2 k O.l** 19 r+_ 3** 2 3.4 * 0.2 
20.0 pM 90 (10) 100 (419)" 2.1 * 0.1** 0.9 r O.l** 16 -t 3** 3 3.3 2 0.2 
'All measurements were made on GD 11.5 after a 26-hour exposure to Z-Phe-Ala-CHN, as described in Materials and Methods. 
Data represent pooled samples from five replicate experiments, except yolk sac diameter, which is from two experiments. ND 
= not determined. 
'Indicates percentage of conceptuses with active heartbeat and yolk sac circulation at the end of the culture period (number 
cultured). 
31ndicates percentage of dysmorphic embryos a t  the end of the culture period (number dysmorphicinumber surviving). For type 
and incidence of dysmorphogenesis, see Table 3. 
*Significantly different from control, P < 0.05. 
**Significantly different from control, P < 0.001. 
TABLE 2. Effect of Z-Phe-Phe-CHN, on rat embryonic develoDment in vitro 
Initial inhibitor Crown-rump Mean volk Total head 
concentration % Viabilityi % Dysmorphic' length (mm % *SD) sac score length (mm f SD) 






100 ( 5 )  0 (015) 3.3 -t 0.2 0 1.6 t 0.1 
100 (10) 30 (3110) 3.1 f 0.2" 1 1.5 -t 0.2''' 
100 (17) 76 (13117) 2.8 * 0.2** 1 1.3 ? 0.2** 
100 (11) 82 (9111) 2.6 2 0.2** 2 1.2 % 0.1** 
100 ( 5 )  100 (515) 2.5 2 0.2** 1 1.2 % 0.1** 
'Indicates number of conceptuses possessing an active heartbeat and yolk sac circulationitotal number cultured (n). 
'Indicates number of morphologically abnormal embryos a t  the end of the culture perioditotal number surviving. (Abnormal- 
ities consisted of any of the following singly or in combination: anophthalmia, microphthalmia, craniofacial hypoplasia, 
craniofacial blisters, shortened tail, abnormal axial rotation, clear neural tube.) 
*Significantly different from control, P < 0.05. 
**Significantly different from control, P < 0.001. 
TABLE 3. Type and incidence of dysmorphogenesis in embryos exposed to Z-Phe-Ala-CHN, in vitro' 
Inhibitor 
DMSO control (31) 0 0 0 0 0 0 3 0 6 
concentration (n) MO' A 0  HP FH BL NC AAR ST CE 
1 FM (5) 0 0 0 0 0 0 0 0 0 
2.5 pM (21) 18 9 27 27 9 0 9 18 0 
5.0 pM (24) 58 29 58 58 8 4 25 33 0 
10.0 pM (25) 8 92 92 92 24 20 28 44 0 
20.0 WM (9) 0 100 100 100 67 78 22 33 0 
'Data represent percentage of surviving embryos possessing the listed abnormality a t  the end of the 26-hour culture period. 
MO = microphthalmia; A 0  = anophthalmia; HP = prosencephalic hypoplasia; FH = flat head; BL = prosencephalic blisters; 
NC = necrosis (head or trunk); AAR = abnormal axial rotation; ST = short, blunt trunk; CE = cloaca1 extrophy. 
'The incidence of microphthalmia peaks in embryos treated with 5.0 pM Z-Phe-Ala-CHN,; at higher concentrations anoph- 
thalmia was observed in nearly every case. 
VYS protein content showed a biphasic response, being 
increased in the 2.5 p M  group (to 113% of control, P < 
0.051, no different than control in the 5 p M  group 
(100% of control), and decreased in VYSs exposed to 
higher concentrations of Z-Phe-Ala-CHN, (to 72% of 
control at 20 pM, P < 0.001). All the treatment groups 
showed an increase in VYS protein content when nor- 
malized t o  DNA content, however. Figure 2 also indi- 
cates that conceptuses exposed to Z-Phe-Phe-CHN2 
throughout the culture period likewise showed a bipha- 
sic response in VYS protein content that did not cor- 
relate with other growth parameters. VYS protein 
content appeared to be increased in all Z-Phe-Phe- 
CHN,-treated groups except the 20 pM group, al- 
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Fig. 2. Effect of peptidyl diazomethanes on biochemical growth pa- 
rameters. Changes in embryonic protein content (A), embryonic DNA 
content (B), VYS protein content (C), and VYS DNA content (D) 
following 26-hour conceptal exposure to Z-Phe-Ala-CHN, or Z-Phe- 
Phe-CHN,. Columns represent means * SEM from "n" samples listed 
in Tables 1 and 2. "Significantly different from control, P <: 0.05. 
**Significantly different from control, P <I 0.001. 
though none of these increases were found t o  be statis- 
tically significant. 
The ability of the peptide diazomethanes to differen- 
tially affect embryonic and VYS protein content be- 
came more apparent if the percentage of serum in the 
culture medium was increased or if the length of expo- 
sure time to the inhibitor was decreased. As illustrated 
in Figure 3 ,  doubling the serum content of the culture 
medium led t o  much larger increases in VYS protein 
content in conceptuses exposed to 2.5 pM of Z-Phe-Ala- 
CHN, than those observed originally (increased to 
134% of control in 66% serum vs. 113% of control in 
33% serum), while embryonic protein content in these 
conceptuses was decreased to an extent similar to that 
observed originally (to 73% of control in 66%) serum vs. 
79% of control in 33% serum). Moreover, whereas con- 
ceptuses exposed to 5 and 10 pM concentrations of 
Z-Phe-Ala-CHN, for 26 hours showed no increase in 
VYS protein content in our original experiments (100% 
of control a t  5 pM; 88% of control at 10 pM), exposure 
t o  these same inhibitor concentrations and media com- 
position (33% serum) for only the final 6 hours of cul- 
ture showed a significant increase in protein content 
(increased to 136% of control at 5 pM, P < 0.01; 130% 
of control a t  10 pM, P < 0.01). 
The effect of peptidyl diazomethanes on lysosomal 
cysteine proteinase activity in GD 11.5 conceptal ex- 
tracts is shown in Figure 4. As expected, Z-Phe-Ala- 
CHN, treatment decreased cathepsin B and L activity 
in a concentration-dependent fashion in the VYS (to 
13% of control a t  20 p,M, P < 0.001). With the excep- 
tion of the 1 pM group, Z-Phe-Phe-CHN, treatment 
also inhibited VYS cathepsin B and L activity in a 
concentration-dependent fashion (to 13% of control at 
20 FM, P < 0.001). As noted previously (Ambroso and 
Harris, '941, VYS lysosomal cysteine proteinase activ- 
ity exceeded that measured in the embryo by nearly 
100-fold (approximately 350 mUimg DNA in control 
VYSs vs. 3 mU/mg DNA in control embryos). Embry- 
onic activity was not inhibited by Z-Phe-Ala-CHN, 
treatment, and was significantly increased at the high- 
est inhibitor concentration tested (to 170% of control a t  
20 pM, P < 0.05). Z-Phe-Phe-CHN, treatment pro- 
duced a biphasic response in embryonic cathepsin B 
and L activity, increasing activity to 213% of control in 
the 2.5 pM group (P < 0.05), but inhibiting this activ- 
ity in the 10 pM group (29% of control, P < 0.05). 
Conceptuses exposed to Z-Phe-Ala-CHN, throughout 
the 26 hour embryo culture period showed dramatic 
histological changes in both the embryo and VYS. In 
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Fig. 3. Effect of medium composition and duration of exposure to  
Z-Phe-Ala-CHN, on VYS protein accumulation in organogenesis- 
stage conceptuses. Conceptuses grown for 26 hours in 6 6 6  serum 
exposed to Z-Phe-Ma-CHN, continuously (A) and conceptuses grown 
for 26 hours in 33% serum and exposed to Z-Phe-Ala-CHN, for only 
the final 6 hours of culture (B). Columns represent means k SD of n 
= 11 (A) or n = 5 (B) samples. ““Significantly different from control. 
P < 0.01. 
the VYS endoderm epithelium, a concentration-depen- 
dent increase in both the size and number of cytoplas- 
mic vacuoles was observed (Fig. 5) .  These vacuoles con- 
tained material which stained pink (eosinophilic) with 
H&E, and is presumably undegraded protein accumu- 
lating in lysosomes. This staining became increasingly 
more abundant and intense as  the concentration of 
Z-Phe-Ala-CHN2 was increased. The cytoplasm of the 
VYS epithelium was also distended and the nuclei 
marginalized, apparently as  a result of the vacuolar 
expansion occurring in the apical region of these cells. 
Histologic examination of transverse sections taken 
from the corresponding embryos revealed extensive 
cell death in the neuroepithelium, craniofacial mesen- 
chyme, otic vesicles, and somites (Fig. 6) which.also 
increased in a clear, concentration-dependent manner. 
Under the light microscope, morphologic changes sug- 
gestive of apoptosis were evident, including nuclear 
condensation, cytoplasmic blebbing, and the presence 
of presumptive apoptotic bodies in the cytoplasm of 
mesenchyme and neuroepithelial cells. When the num- 
ber of cells showing evidence of apoptosis was counted 
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Fig. 4. Effect of 26-hour conceptal exposure to Z-Phe-Ala-CHN, or 
Z-Phe-Phe-CHN, on lysosomal cysteine proteinase activity. VYS (A) 
and embryo rB) tissue extracts. Columns represent means _t SEM 
from “n” samples listed in Tables 1 and 2. *Significantly different 
from control, P < 0.05. **Significantly different from control, P < 
0.001. 
found to be increased over controls (data not shown). A 
pronounced reduction in the thickness of the neuroep- 
ithelium of Z-Phe-Ala-CHN,-treated embryos was 
noted. Cell death appeared to be occurring throughout 
the neural tube, but was localized in specific regions of 
the mesenchyme such as  the branchial arches, the pri- 
mordia of the cranial nerves, and areas near the optic 
vesicles and the nasal placodes. In  some embryos 
treated with higher concentrations of inhibitor, a com- 
plete absence of mesenchymal cells was observed in the 
rostra1 forebrain region, associated with blistering of 
the overlying surface ectoderm. These embryos also 
lacked any indication of optic vesicle formation. 
The selectivity of Z-Phe-Ala-CHN2-induced cell 
death could be appreciated by its absence in many ar- 
eas of the embryonic mesenchyme and in certain other 
tissues, such as  the heart, primitive gut, and VYS. 
Even a t  concentrations of Z-Phe-Ala-CHN, which se- 
verely damaged much of the neuroepithelium, somites, 
and cranial neural crest cells, little or no evidence of 
cell death was observed in these other tissues. Close 
examination of the regions of cell death revealed ap- 
parently phagocytic cells containing two types of cyto- 
plasmic vacuoles-dense basophilic granules with the 
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Fig. 5. Z-Phe-Ala-CHN, alters VYS histology. A Transverse sec- 
tion of a control VYS. The cytoplasm of the endoderm epithelium (E) 
contains many small absorptive vacuoles that appear clear or stain 
faint pink with H&E. M = mesothelial layer; V = vitelline vascula- 
ture. x 600. B: Similar section of a 5 FM 2-Phe-Ala-CHN,-treated 
VYS. Note reduced size of the vitelline vasculature, and distension of 
the epithelial cytoplasm. The epithelial nuclei (arrow) have been mar- 
ginalized by large cytoplasmic vacuoles containing material that 
stains bright pink (eosinophilic) with H&E. x 600. 
characteristic appearance of apoptotic bodies and primordia of an  inhibitor-treated embryo which has the 
eosinophilic vacuoles reminiscent of those observed in morphologic appearance of apoptosis. 
the VYS epithelium (Fig. 7). Figure 7 also shows mas- The induction of apoptosis in embryos treated with 
sive cell death occurring in the trigeminal ganglion Z-Phe-Ala-CHN, was further evaluated by supravital 
Fig. 6. Effects of 2-Phe-Ala-CHN, exposure on embryo histology. 
A Transverse section of a control embryo forebrain (F) and optic 
vesicle (0) from the level of Rathke’s pouch. Occasional cells under- 
going cell death (arrow) can be observed. NE = neuroepithelium: NP 
= nasal placode. H&E. X 240. B: Similar section as A from an embryo 
exposed to 2.5 p,M Z-Phe-Ala-CHN,. The optic vesicle is underdevel- 
oped, and the thickness of the neuroepithelium is reduced. Increased 
cell death is observed in the neuroepithelium (white arrowhead) and 
in the mesenchyme (black arrows) between the optic vesicle and the 
nasal placode. x 240. C: Similar section as  A from an  embryo exposed 
to 10 p,M Z-Phe-Ala-CI-IN,. Note the complete absence of optic vesicle 
formation and massive cell death in the neuroepithelium and mesen- 
chyme. The most rostra1 aspect of the prosencephalon is devoid of 
underlying mesenchyme, and a blister (B) is apparent in the surface 
ectoderm (El. Arrows indicate mesenchymal cells presumed to contain 
phagocytized cell debris. x 240. 
Fig. 7. Z-Phe-Ala-CHN, elicits selective cell death in the craniofa- 
cia1 mesenchyme. A: Photomicrograph of a control neuroepithelium 
and mesenchyme on GD 11.5. The area shown is just ventral to  the 
optic vesicle. Occasional evidence of cell death can be observed iar- 
row). H&E. x 980. B: Similar section as A from a 2.5 ELM Z-Phe-Ala- 
CHN,-treated embryo. Note excessive cell death in both the neuroep- 
ithelium and underlying mesenchyme. Many cells contain inclusions 
which fit a morphologic description of apoptotic bodies (arrows), and 
stain with hematoxylin. Additional cytoplasmic vacuoles, containing 
eosinophilic material, can also be found in the same cells (arrowhead). 
x 980. C: Histology of control dorsal trigeminal neural crest. Again, 
occasional cell death can be observed (arrow). x 600. D: Similar sec- 
tion as C from an embryo exposed to  5.0 mM 2-Phe-Ala-CHN,. Mas- 
sive cell death is observed, with apparent phagocytosis. These alter- 
ations were not observed in adjacent populations of mesenchymal 
cells. ~ 6 0 0 .  
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Fig. 8. NBS staining of GD 11.5 embryos, showing sites of cell 
death. A: Darkfield micrograph of a control embryo which shows 
staining in characteristic areas, such as the choroid fissure of the optic 
vesicle and cranial nerve primordia (arrowheads). The nasal placode 
is out of the plane of focus but also shows some staining. x30. B 
Embryo exposed to 2.5 pM Z-Phe-Ala-CHN,, also stained with NBS. 
The cranial nerves, nasal placode, otic vesicle, and somites are par- 
ticularly sensitive and are clearly delineated in this embryo, while 
the heart is relatively free of staining. x 30. 
staining with NBS, a classic technique used to evaluate 
embryonic cell death. NBS has been found to stain re- 
gions of normal programmed cell death (PCD) and also 
chemical-induced cell death in embryos from a variety 
of species (reviewed by Saunders, '66; Menkes et al., 
'70; Sulik e t  al., '88). In controls exposed t o  DMSO ve- 
hicle alone, NBS staining was observed in areas of the 
embryo where normal PCD has been described, such as 
the nasal placode, cranial nerves, and the choroid fis- 
sure of the optic vesicle. In contrast, embryos treated 
with Z-Phe-Ala-CHN, exhibited a concentration-re- 
lated increase in the area and intensity of NBS stain- 
ing compared to that observed in controls (Fig. 8). 
Leupeptin treatment was also observed to increase the 
distribution and intensity of NBS staining in embryos 
after similar exposure regimens (data not shown). 
DISCUSSION 
We have provided biochemical and histological evi- 
dence indicating that Z-Phe-Ala-CHN, and Z-Phe-Phe- 
CHN, inhibit VYS proteolysis in organogenesis-stage 
conceptuses in vitro. VYS cathepsin B and L activity in 
conceptuses treated with the inhibitors decreased in a 
concentration-dependent fashion and appeared to cor- 
relate with other indicators of embryotoxicity such as 
decreased embryonic protein content, DNA content, 
and crown-rump length. Although Daston et al. ('91) 
and Grubb et al. ('91) have measured constitutive ly- 
sosomal cysteine proteinase activity in GD 12.5 concep- 
tuses, we believe that the present study is the first to 
demonstrate inhibition of this activity in conceptuses 
exposed to proteinase inhibitors. It should be noted, 
however, that these measurements of enzyme activity 
were made at  the end of the culture period, and may 
not reflect the degree of inhibition achieved a t  earlier 
time points or the total amount of enzyme present (but 
rather only active enzyme). Because of the ability of rat 
conceptuses to upregulate lysosomal cysteine protein- 
ase activity following exposure to reversible inhibitors 
(Ambroso and Harris, '941, we would predict that in 
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conceptuses treated with peptidyl diazomethanes, VYS 
cathepsin B and L activity might be inhibited by an 
even greater extent at earlier time points, and thus 
toxicity may correlate better with the duration rather 
than extent of inhibition. 
A characteristic finding in conceptuses exposed to 
protease inhibitors such as leupeptin is an increase in 
VYS protein content, due to an accumulation of unde- 
graded protein in the vacuoles of the VYS epithelium 
(Freeman and Lloyd, '83b, '86; Daston et al., '911. This 
change is observed even though the overall growth of 
the VYS (yolk sac diameter) is retarded by leupeptin 
treatment. In the present study, we observed only a 
small increase in VYS protein content in conceptuses 
exposed to 2.5 FM Z-Phe-Ala-CHN, after a 26 hour 
exposure period, although the pattern of changes ob- 
served in VYS DNA and protein content in response to 
peptidyl diazomethane treatment was suggestive of in- 
hibition of VYS proteolysis. If the serum content of the 
medium was increased, however, more obvious in- 
creases in VYS protein content were observed. This 
was also true if Z-Phe-Ala-CHN, exposure was limited 
to only the final 6 hours of culture (as in Freeman and 
Lloyd, '83b), rather than the full 26 hour period. Thus, 
the ability of Z-Phe-Ala-CHN, (and most likely Z-Phe- 
Phe-CHN,) to increase VYS protein content in vitro is 
dependent upon both the protein content of the medium 
and the exposure time. The lack of a dramatic increase 
in VYS protein content in our initial studies is at least 
partly due to the lower serum content of our culture 
medium (33%) compared with previous studies (which 
typically used 50-100% serum), and it appears that 
shorter exposure periods may also contribute to the 
more dramatic increases in protein content observed in 
some cases (Freeman and Lloyd, '83b, '86). Ibbotson 
and Williams ('79) have shown that fluid-phase pinocy- 
tosis in cultured GD 17.5 VYSs is increased in serum- 
free medium, but it is unknown whether this phenom- 
enon is a factor in our experiments. 
Although VYS protein content in Z-Phe-Ala-CHN,- 
treated conceptuses showed a biphasic response, a 
concentration-dependent accumulation of eosinophilic 
material (presumably undegraded protein) in vacuoles 
of the VYS epithelium was clearly apparent in 
histological sections prepared from these conceptuses. 
Such changes in VYS histology are consistent with 
changes observed in conceptuses exposed to other 
agents known to inhibit VYS proteolysis (Beck and 
Lowy, '82; Daston et al., '91; Hunter et al., '91). 
ProteiniDNA ratios in the VYS were also found to be 
increased in all treatment groups. These data suggest 
that protein accumulation does occur in the vacuolar 
system of Z-Phe-Ala-CHN,-treated VYSs and that the 
decrease of VYS protein content seen at higher 
concentrations is most likely due to decreased overall 
growth of the VYS. 
The data presented above argue in favor of inhibition 
of VYS proteolysis and therefore disruption of his- 
tiotrophic nutrition as the likely cause of Z-Phe-Ala- 
CHNz and Z-Phe-Phe-CHN, embryotoxicity in vitro. 
This conclusion is further supported by recent experi- 
ments in which conceptuses exposed to Z-Phe-Ala- 
CHN, accumulated exogenously administered fluores- 
cein-labeled proteins in their VYSs (Ambroso and 
Harris, unpublished observations). Thus the present 
study appears to support the contention that lysosomal 
cysteine proteinases are responsible for VYS proteoly- 
sis and are the target for leupeptin- and peptidyl dia- 
zomethane-induced embryotoxicity. Although no pre- 
vious studies have distinguished between cathepsins B, 
H, and L during the critical period of early organogen- 
esis, available evidence suggests that cathepsin H is 
not of primary importance for VYS proteolysis. First, 
cathepsin H is known to be relatively resistant to in- 
hibition by leupeptin compared to cathepsins B and L 
(Barrett and Kirschke, '81); second, both Daston et al. 
('91) and Grubb et al. ('91) found very low levels of 
cathepsin H activity in GD 12.5 VYSs. Our results fur- 
ther discount the role of cathepsin H as a primary fac- 
tor in VYS proteolysis because the peptidyl diaz- 
omethanes have also been found to be poor inhibitors of 
this enzyme compared to cathepsins B and L (Kirschke 
et al., '80). 
Distinctions have been made between cathepsin B 
and cathepsin L on the basis of the relative sensitivi- 
ties of these enzymes to Z-Phe-Ala-CHN, and Z-Phe- 
Phe-CHN, (Kirschke et al., '80; Kirshke and Shaw, '81; 
Kirschke and Barrett, '87). The latter studies found 
cathepsin L to be inactivated much more rapidly than 
cathepsin B by both of these inhibitors. Unfortunately, 
the exposure times used in the present study are too 
long to allow us to make such distinctions for the rat 
VYS. Further studies with these inhibitors are under- 
way which aim to clarify the roles of cathepsin B and 
cathepsin L in VYS proteolysis. 
In addition to providing information about the iden- 
tity of proteolytic enzymes involved in histiotrophic nu- 
trition, the embryotoxic potential of peptidyl diaz- 
omethanes and related cysteine proteinase inhibitors is 
also of interest because of their possible use as thera- 
peutic agents in animal and human disease. Remark- 
ably, lysosomal cysteine proteinases have been identi- 
fied in a number of human parasites and are believed 
to be important in their pathogenesis: Plasmodium fal-  
ciparum (Rosenthal et al., '88), Trypanosoma cruzi 
(Cazzulo et al., '901, Leishmania amazonensis (Alfieri 
et al., '911, and Clonorchis sinensis (Song and Rege, 
'91), among others. Altered cellular production and ac- 
tivity of lysosomal cysteine proteinases have also been 
associated with tumor progression and metastatic po- 
tential (Sloane et al., '92; Lah et al., '92; van der Stap- 
pen et al., '91), as well as with arthritic lesions in both 
rodents and man (Van Noorden et al., '88; Huet et al., 
'92). In at least two of the examples listed above, cys- 
teine proteinase inhibitors resembling peptidyl diaz- 
omethanes have been successful as therapeutic agents 
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in animal models of human disease (Van Noorden et  
al., '88; Rosenthal et al., '93). 
A striking and unexpected histological observation 
was the extensive cell death occurring in embryonic 
tissues of conceptuses exposed to Z-Phe-Ala-CHN,. 
Embryos recovered after the 26 hour culture period 
showed evidence of massive apoptosis in the neuroepi- 
thelium and in selective regions of the craniofacial 
mesenchyme. Follow-up experiments demonstrated 
that embryos exposed to Z-Phe-Ala-CHN, stained in- 
tensely with NBS in areas where histological evidence 
of excessive cell death had been observed. The somites 
and the cranial nerve primordia appeared to be partic- 
ularly susceptible, while other tissues such as the heart 
were relatively resistant. If one accepts the premise 
that chemical insult expands areas of normal PCD (Su- 
lik e t  al., '881, then the resistance of the rat  heart to cell 
death in the present study can be explained by the fact 
that normal PCD does not occur in this tissue until 
about GD 14 (Pexieder, '75). The GD 11 rat heart has 
also been noted to be resistant to heat shock-induced 
cell death (Mirkes, '85). 
Although cell death is a common response of embry- 
onic tissues to a variety of teratogenic insults, i t  has 
not previously been reported in conceptuses exposed to 
proteolytic enzyme inhibitors. Daston et al. ('91) ob- 
served a decrease in neural tube volume in GD 12 rat 
embryos exposed to leupeptin for 48 hours, but made no 
mention of cell death. This appears to contradict our 
observation that leupeptin treatment also increases 
NBS staining in GD 11 embryos. It has been noted, 
however, that because of the rapid removal of apoptotic 
bodies by neighboring cells, the histologic appearance 
of apoptosis is transitory and not always readily ob- 
servable microscopically (Bursch et  al., '90; Kerr and 
Harmon, '911. 
Sulik et al. ('88) and others have proposed that dam- 
age of the cranial neural crest may be responsible for 
craniofacial abnormalities observed in children and an- 
imals exposed to ethanol and retanoic acid in utero. 
There is a remarkable similarity between the pattern 
of NBS staining observed in Z-Phe-Ala-CHN,-treated 
embryos and the migratory pathways of cephalic neu- 
ral crest cells as  determined by fate mapping experi- 
ments (Noden, '75; Tan and Morris-Kay, '86; Serbedzija 
et al., '92). This supports previous suggestions that the 
cranial neural crest, in addition to the neuroepithe- 
lium, is particularly vulnerable t o  chemical insult near 
the time of neural tube closure. As pointed out by Sulik 
et al. ('87), however, cells derived from the ectodermal 
placodes of the visceral arches (ganglionic placodes) 
also populate the distal regions of the cranial nerves 
and may be the primary targets in cases where the 
exposure occurs near the end of neural crest migration 
(GD 9 in the mouse). Our exposure period appears to 
approximate GD 8.5-9.5 in the mouse, and might be 
predicted to affect both neural crest and ectodermal 
placode derivatives. The pattern of cell death observed 
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in our embryos would seem to confirm this, since cells 
in both the proximal and distal portions of the trigem- 
inal nerve were affected as well as cells in the visceral 
arch mesenchyme (which migrate earlier than the gan- 
glionic placode cells). 
At present, we can only speculate about how Z-Phe- 
Ala-CHN,, a compound thought to be extremely selec- 
tive in terms of its inhibitory effects and reactivity, 
might cause cell death in our embryos. One could easily 
envision that apoptosis might result from an  interrup- 
tion of histiotrophic nutrition, since physiological 
changes such as growth factor withdrawal or vitamin 
deficiency have previously been reported to induce ap- 
optotic cell death in developing tissues (Menkes et al., 
'70; Barres et al., '92; Pesce et al., '93). A particularly 
interesting hypothesis is that disruption of normal nu- 
tritional pathways might lead to a decrease in trophic 
factors which normally suppress apoptosis. Certain 
cells, such as the migrating neural crest, may be par- 
ticularly susceptible because of their dependence on 
environmental factors for survival and differentiation 
(reviewed by Stemple and Anderson, '93). 
An alternative explanation for the observed cell 
death is that Z-Phe-Ala-CHN2 alkylates indiscrimi- 
nately, and is therefore directly cytotoxic to embryonic 
cells. This hypothesis seems unlikely because of the 
specificity of peptidyl diazomethylketones, which act as 
affinity labels for lysosomal cysteine proteinases and 
are relatively non-reactive toward nucleophiles other 
than the active site thiol of these enzymes. Other thiols 
(such as  DTT and glutathione) do not react signifi- 
cantly with these compounds, and neither do the alco- 
hols present in the active site of serine proteases (re- 
viewed by Shaw, '90). One might also argue that the 
inhibitor does not reach target sites in the embryo 
proper, since Z-Phe-Ala-CHN, treatment did not in- 
hibit cathepsin activity in embryonic tissues. Any in- 
hibition of enzyme activity in embryonic tissues may 
be masked, however, by the adaptive response de- 
scribed in our previous study (Ambroso and Harris, 
'94). In that study, the embryo was found to be partic- 
ularly responsive in terms of its ability to upregulate 
lysosomal cysteine prot.einase activity. Thus, without 
measuring enzyme content, we cannot state with cer- 
tainty that the inhibitor fails to reach embryonic tis- 
sues. Indeed, one of our speculations is that there are 
direct effects of the inhibitor on the embryo proper, in 
addition to the indirect effects mediated through the 
VYS. This is mainly a result of the observation of large, 
intensely stained eosinophilic vacuoles in cells associ- 
ated with areas of cell death in inhibitor-treated em- 
bryos. While such an effect could be due to a normal 
increase in lysosomal enzymes seen in response to cell 
death (Ballard and Holt, '68), i t  may indicate that the 
lysosomal degradation of cell debris is inhibited by 
Z-Phe-Ala-CHN,. If this is the case, apoptosis may be 
more apparent histologically because of slowed clear- 
ance. Clearly, further experimentation is required be- 
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fore the ultimate cause of embryonic cell death in 
Z-Phe-Ala-CHN,-treated conceptuses is ascertained. 
In summary, our results indicate that the peptidyl 
diazomethanes are potent in vitro embryotoxicants and 
strong candidates for in vivo teratogens. In addition to 
causing dramatic growth retardation and dysmorpho- 
genesis in organogenesis-stage rat conceptuses grown 
in whole embryo culture, Z-Phe-Ala-CHN, treatment 
produces at  least two characteristic histological 
changes that have frequently been associated with ex- 
posure to teratogenic agents: 1) an increase in the size 
and number of cytoplasmic vacuoles in the VYS endo- 
derm epithelium (resembling lysosomal storage dis- 
ease), and 2) selective cell death in the embryo proper. 
The peptidyl diazomethanes appear to act primarily by 
disrupting VYS proteolysis, which is rate-limited by 
the activity of lysosomal cysteine proteinases. Further 
experiments with the peptidyl diazomethanes may lead 
to more comprehensive characterization of these en- 
zymes in early organogenesis-stage conceptuses. These 
findings also suggest that the therapeutic use of cys- 
teine proteinase inhibitors should be critically evalu- 
ated with regard to their developmental toxicology. 
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